We have approved
this survey of consumers' comestic usage patterns, and acknoweldge
FDA's reply to the preceding terms of clearance. FDA has noted that
this survey itself will not be used for regulatory purposes, but
rather to produce general comestic usage data that may direct
future, more specific risk assessment research. Except in clea cut
cases of acute threats to health, FDA usually will have to conduct
short-term, product specific follow-up surveys prior to regulatory
action against certain cosmetics. FDA has agreed to revise question
1 page 10, as per its memo of August 25, 1993.
Inventory as of this Action
Requested
Previously Approved
03/31/1994
03/31/1994
1,650
0
0
413
0
0
0
0
0
FDA NEEDS INFORMATION ON COSMETIC
USAGE PATTERNS AMONG CONSUMERS TO IMPROVE ITS RISK MANAGEMENT
PROCESS FOR COSMETICS BY BASING THIS PROCESS AS MUCH AS POSSIBLE ON
SCIENTIFICALLY SOUND RISK ASSESSMENTS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.